| Literature DB >> 33671467 |
Luigi Napolitano1, Biagio Barone1, Simone Morra1, Giuseppe Celentano1, Roberto La Rocca1, Marco Capece1, Vincenzo Morgera1, Carmine Turco1, Vincenzo Francesco Caputo1, Gianluca Spena1, Lorenzo Romano1, Luigi De Luca1, Gianluigi Califano1, Claudia Collà Ruvolo1, Francesco Mangiapia1, Vincenzo Mirone1, Nicola Longo1, Massimiliano Creta1.
Abstract
Prader-Willi syndrome (PWS) is a multisystemic complex genetic disorder related to the lack of a functional paternal copy of chromosome 15q11-q13. Several clinical manifestations are reported, such as short stature, cognitive and behavioral disability, temperature instability, hypotonia, hypersomnia, hyperphagia, and multiple endocrine abnormalities, including growth hormone deficiency and hypogonadism. The hypogonadism in PWS is due to central and peripheral mechanisms involving the hypothalamus-pituitary-gonadal axis. The early diagnosis and management of hypogonadism in PWS are both important for physicians in order to reach a better quality of life for these patients. The aim of this study is to summarize and investigate causes and possible therapies for hypogonadism in PWS. Additional studies are further needed to clarify the role of different genes related to hypogonadism and to establish a common and evidence-based therapy.Entities:
Keywords: Prader-Willi syndrome; chromosome 15 abnormalities; genomic imprinting; hypogonadism
Mesh:
Substances:
Year: 2021 PMID: 33671467 PMCID: PMC7922674 DOI: 10.3390/ijms22041993
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923